Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells

• Published in: Transplantation and cellular therapy Vol. 28; no. 3; p. S201
• Main Authors: Aldoss, Ibrahim, Khaled, Samer K., Blanchard, M. Suzette, Wang, Xiuli, Wagner, Jamie R., Clark, Mary, Simpson, Jennifer, Paul, Jinny, Stein, Anthony S., Pullarkat, Vinod, Salhotra, Amandeep, Al Malki, Monzr M., Thomas, Sandra, Budde, Lihua E., Marcucci, Guido, Brown, Christine E., Forman, Stephen J.
• Format: Journal Article
• Language: English
• Published: 01.03.2022